Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension

Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness for group 1 PAH in APS patient may contribute to underdiagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Jina, Shin, Nami, Ahn, Kyung-Jin, Seo, Miryoung, Jang, Albert Youngwoo, Kim, Minsu, Chung, Wook-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973988/
https://www.ncbi.nlm.nih.gov/pubmed/35361265
http://dx.doi.org/10.1186/s40885-021-00191-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973988/
https://www.ncbi.nlm.nih.gov/pubmed/35361265
http://dx.doi.org/10.1186/s40885-021-00191-1

Ejemplares similares